Vasalgel

Ed Gillis travels to advance Vasalgel

Ed Gillis, CEO of Revolution Contraceptives, the social venture company tasked with developing Vasalgel for Parsemus Foundation, traveled to Paris this spring to exchange ideas with other male contraceptive innovators at the second International Congress on Male Contraception. He aimed to network with others in the field, learn about other male contraceptives in development, and… Read more


Vasalgel highlighted in list of reproductive advances

Vasalgel made the Daily Beast’s list of the medical advances in 2017 that “are going to not only dramatically transform how we think about the birds and the bees but also the very way we think about reproduction.” In the December 25, 2017 article by senior science editor Tanya Basu, Vasalgel was heralded as the frontrunner… Read more


Study: new male contraceptives will reduce unintended pregnancies

How will the availability of new male contraceptive options impact the number of unintended pregnancies? Researchers recently created a model to answer that question in a paper published in Contraception. They focused the analysis on three countries (United States, South Africa and Nigeria) which differed by the type and rate of contraceptive use. By analyzing… Read more


Success! Publication of Vasalgel reversal study

Successful reversal of Vasalgel male contraceptive in rabbits For immediate release: Vasalgel’s prevention of sperm transport in the vas deferens for 14 months was reversed through an injection of sodium bicarbonate. Sperm concentration and motility returned to baseline. Results of a study of a promising new male contraceptive called VasalgelTM were published today in Basic… Read more


Publication of monkey results receives great media attention

Vasalgel given to 16 monkeys resulted in 100% successful contraception — no pregnancies after 1 to 2 years. The results, published in Basic and Clinical Andrology, also showed that Vasalgel was well-tolerated in the monkeys, who had fewer complications than a control group receiving vasectomy. The results are important to the development of Vasalgel as a… Read more


Successful application of Vasalgel™ male contraceptive in monkeys

Press Release Monday, Feb. 6, 2017 20:00 EST New contraceptive Vasalgel provides effective birth control in rhesus monkey groups for more than one year: report from California National Primate Research Center Results of a study of Vasalgel in rhesus macaques were published today in Basic and Clinical Andrology. Vasalgel is being developed by a social… Read more